Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.08% Nasdaq Down0.83%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
1.23 Down 0.03(2.00%) 4:00PM EDT
- Nasdaq Real Time Price
Get the big picture on all your investments.
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.3
Mean Recommendation (last week):2.3
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:5.69
Median Target:4.75
High Target:12.00
Low Target:1.25
No. of Brokers:4

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Dec 12, 2013MLV & CoDowngradeBuyHold
Sep 6, 2012Maxim GroupInitiated Buy
May 15, 2012MLV & CoInitiated Buy
Feb 17, 2012Cowen & CoInitiated Neutral
Dec 1, 2011Global Hunter SecuritiesInitiated Buy
Mar 22, 2011Dawson JamesInitiated Buy
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1111
Buy1111
Hold2222
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.